SCHEMBL30982152

SCHEMBL30982152

COC(=O)c1ncc2cc(C=O)ccn12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.41
SMN1; SMN2 Q16637 4/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 3/20 0.35
HPGD P15428 2/20 0.35
CYP1A2 P05177 1/20 0.35
HSP90AA1 P07900 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 4/20 0.34
HSD17B10 Q99714 2/20 0.34
TSHR P16473 2/20 0.33
ALOX15 P16050 1/20 0.33
GLA P06280 1/20 0.33
ATM Q13315 1/20 0.33
AOX1 Q06278 1/20 0.33
MAPK1 P28482 1/20 0.33
TRIM24 O15164 1/20 0.33
ALDH5A1 P51649 1/20 0.33
ABAT P80404 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30982194 0.88 IRAK4 (0.35) ALDH1A1SMN1; SMN2GAAMAPTHPGD
SCHEMBL26693606 0.80 HSD17B10 (0.40) ALDH1A1SMN1; SMN2GAAHPGDKDM4E
SCHEMBL31447720 0.75 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2GAAMAPTHPGD
SCHEMBL30204796 0.73 HSD17B10 (0.42) ALDH1A1GAAMAPTHPGDKDM4E
SCHEMBL26694058 0.69 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2GAAHPGDKDM4E
SCHEMBL30204305 0.67 JMJD6 (0.43) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL14738044 0.67 SSTR4 (0.43) ALDH1A1SMN1; SMN2MAPTKDM4EATM
SCHEMBL13266511 0.67 KDM4E (0.57) ALDH1A1SMN1; SMN2MAPTHPGDKDM4E
SCHEMBL29277572 0.67 TSHR (0.37) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL5030728 0.67 TGFBR1 (0.45) ALDH1A1SMN1; SMN2GAAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024153595-A1 CHROMANE DERIVATIVES AS EGFR SELECTIVE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2024-07-25 WO disclosed